Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

被引：356

作者：

Fukagawa, Masafumi ^{[1
]}

Yokoyama, Keitaro ^{[1
]}

Koiwa, Fumihiko ^{[1
]}

Taniguchi, Masatomo ^{[1
]}

Shoji, Tetsuo ^{[1
]}

Kazama, Junichiro James ^{[1
]}

Komaba, Hirotaka ^{[1
]}

Ando, Ryoichi ^{[1
]}

Kakuta, Takatoshi ^{[1
]}

Fujii, Hideki ^{[1
]}

Nakayama, Msasaaki ^{[1
]}

Shibagaki, Yugo ^{[1
]}

Fukumoto, Seiji ^{[2
]}

Fujii, Naohiko ^{[1
]}

Hattori, Motoshi ^{[1
]}

Ashida, Akira ^{[1
]}

Iseki, Kunitoshi ^{[1
]}

Shigematsu, Takashi ^{[1
]}

Tsukamoto, Yusuke ^{[1
]}

Tsubakihara, Yoshiharu ^{[1
]}

Tomo, Tadashi ^{[1
]}

Hirakata, Hideki ^{[1
]}

Akizawa, Tadao ^{[1
]}

机构：

[1] Japanese Soc Dialysis Therapy, Tokyo, Japan

[2] Japanese Soc Nephrol, Tokyo, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2013年 / 17卷 / 03期

关键词：

Chronic kidney disease-Mineral and Bone Disorders; Clinical practice guideline; Parathyroid hormone; Serum Calcium; Serum phosphorus; Vascular calcification; CHRONIC-RENAL-FAILURE; CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR; 23; ACTIVE VITAMIN-D; AMBULATORY PERITONEAL-DIALYSIS; PARATHYROID-HORMONE LEVELS; ETHANOL INJECTION THERAPY; BETA(2)-MICROGLOBULIN ADSORPTION COLUMN; CHRONIC-HEMODIALYSIS PATIENTS; SERUM ALKALINE-PHOSPHATASE;

D O I：

10.1111/1744-9987.12058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：247 / 288

页数：42

共 370 条

[1]

Aalten J, 2010, CLIN NEPHROL, V74, P433

[2] Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism [J].

Abdelhadi, M ;

Nordenstrom, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :3845-3851

[3] Effect of β2-microglobulin adsorption column on dialysis-related amyloidosis [J].

Abe, T ;

Uchita, K ;

Orita, H ;

Kamimura, M ;

Oda, M ;

Hasegawa, H ;

Kobata, H ;

Fukunishi, M ;

Shimazaki, M ;

Abe, T ;

Akizawa, T ;

Ahmad, S .

KIDNEY INTERNATIONAL, 2003, 64 (04) :1522-1528

[4] Serum Alkaline Phosphatase and Phosphate and Risk of Mortality and Hospitalization [J].

Abramowitz, Matthew ;

Muntner, Paul ;

Coco, Maria ;

Southern, William ;

Lotwin, Irwin ;

Hostetter, Thomas H. ;

Melamed, Michal L. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (06) :1064-1071

[5] Influence of lipid-lowering therapy on the progression of coronary artery calcification - A prospective evaluation [J].

Achenbach, S ;

Ropers, D ;

Pohle, K ;

Leber, A ;

Thilo, C ;

Knez, A ;

Menendez, T ;

Maeffert, R ;

Kusus, M ;

Regenfus, M ;

Bickel, A ;

Haberl, R ;

Steinbeck, G ;

Moshage, W ;

Daniel, WG .

CIRCULATION, 2002, 106 (09) :1077-1082

[6] Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD [J].

Adeney, Kathryn L. ;

Siscovick, David S. ;

Ix, Joachim H. ;

Seliger, Stephen L. ;

Shlipak, Michael G. ;

Jenny, Nancy S. ;

Kestenbaum, Bryan R. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (02) :381-387

[7] Can DXA Predict Fractures in Renal Transplant Patients? [J].

Akaberi, S. ;

Simonsen, O. ;

Lindergard, B. ;

Nyberg, G. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (12) :2647-2651

[8] Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study [J].

Al-Baaj, F ;

Speake, M ;

Hutchison, AJ .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) :775-782

[9] Vitamin D and kidney disease [J].

Al-Badr, Wisam ;

Martin, Kevin J. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05) :1555-1560

[10]

Albright F, 1937, B JOHNS HOPKINS HOSP, V60, P377

← 1 2 3 4 5 6 7 8 9 10 →